SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001599901-23-000019
Filing Date
2023-04-28
Accepted
2023-04-28 16:06:31
Documents
20

Document Format Files

Seq Description Document Type Size
1 DEF 14A rna-20230427.htm   iXBRL DEF 14A 826331
6 rna-20230427_g1.jpg GRAPHIC 43016
7 rna-20230427_g2.jpg GRAPHIC 36406
8 rna-20230427_g3.jpg GRAPHIC 119401
9 rna-20230427_g4.jpg GRAPHIC 118794
10 rna-20230427_g5.jpg GRAPHIC 101505
11 rna-20230427_g6.jpg GRAPHIC 68418
  Complete submission text file 0001599901-23-000019.txt   2633486

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rna-20230427.xsd EX-101.SCH 3352
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rna-20230427_def.xml EX-101.DEF 4273
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rna-20230427_lab.xml EX-101.LAB 5848
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rna-20230427_pre.xml EX-101.PRE 3278
14 EXTRACTED XBRL INSTANCE DOCUMENT rna-20230427_htm.xml XML 142094
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39321 | Film No.: 23865956
SIC: 2834 Pharmaceutical Preparations